PARP1 and neoplasm: In addition to ATR, HR‐deficient tumor cells are also increasingly reliant on other alternative repair pathways such as a type of a‐EJ, named microhomology‐mediated end joining (MMEJ) for survival, suggesting the potential of cotargeting PARP and key members of MMEJ.21